FEB 07, 2019
Academy Continues to Make the Case for IRIS Registry’s Ability to Transform Federal Policies
Top FDA and CMS officials continue to hear about the powerful role that that ophthalmology’s IRIS Registry can play in delivering quality care and independent data.